These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34023295)

  • 1. Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine.
    Feng F; Shen B; Mou X; Li Y; Li H
    J Genet Genomics; 2021 Jul; 48(7):540-551. PubMed ID: 34023295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in patient-derived liver cancer cell models: a step forward for precision medicine.
    Zhang Z; Hui L
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1707-1717. PubMed ID: 37766458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Genome for Drug Response Prediction.
    Pepe G; Carrino C; Parca L; Helmer-Citterich M
    Methods Mol Biol; 2022; 2449():187-196. PubMed ID: 35507263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches.
    Güvenç Paltun B; Mamitsuka H; Kaski S
    Brief Bioinform; 2021 Jan; 22(1):346-359. PubMed ID: 31838491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Cancer Medicine: An Organoid Approach.
    Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
    Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. personalized medicine and pharmacogenomics: ethical and social challenges.
    Lee SS
    Per Med; 2005 Mar; 2(1):29-35. PubMed ID: 29793238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
    Pisanu C; Heilbronner U; Squassina A
    Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products.
    Zhou Y; Peng S; Wang H; Cai X; Wang Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison and validation of genomic predictors for anticancer drug sensitivity.
    Papillon-Cavanagh S; De Jay N; Hachem N; Olsen C; Bontempi G; Aerts HJ; Quackenbush J; Haibe-Kains B
    J Am Med Inform Assoc; 2013; 20(4):597-602. PubMed ID: 23355484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indo-Swiss symposium on advances in pharmacogenomic strategies for implementation of personalized medicine.
    Xaviar S; Kumar S; Ramasamy K; Chakradhara Rao US
    Pharmacogenomics; 2021 Jan; 22(2):67-71. PubMed ID: 33305611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of response to drug therapy in psychiatric disorders.
    Stern S; Linker S; Vadodaria KC; Marchetto MC; Gage FH
    Open Biol; 2018 May; 8(5):. PubMed ID: 29794033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Deep Learning Framework for Predicting Response to Therapy in Cancer.
    Sakellaropoulos T; Vougas K; Narang S; Koinis F; Kotsinas A; Polyzos A; Moss TJ; Piha-Paul S; Zhou H; Kardala E; Damianidou E; Alexopoulos LG; Aifantis I; Townsend PA; Panayiotidis MI; Sfikakis P; Bartek J; Fitzgerald RC; Thanos D; Mills Shaw KR; Petty R; Tsirigos A; Gorgoulis VG
    Cell Rep; 2019 Dec; 29(11):3367-3373.e4. PubMed ID: 31825821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PANCDR: precise medicine prediction using an adversarial network for cancer drug response.
    Kim J; Park SH; Lee H
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38487849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
    Lauschke VM; Milani L; Ingelman-Sundberg M
    AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics/updated for precision medicine in dermatology.
    Do LHD; Maibach H
    J Dermatolog Treat; 2019 Jun; 30(4):410-413. PubMed ID: 30238807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.